Thanks for that OlliePop - it is very interesting.

The authors of the paper in your link have made some progress since then; Human serum antibodies against EBV latent membrane protein 1 cross-react with α-synuclein. - PubMed - NCBI (free access).

Clearly there is more work to be done but this looks very promising to me.